866-997-4948(US-Canada Toll Free)

Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Aug 2018

Category :

In Vitro Diagnostics

No. of Pages : 161 Pages

Liquid Biopsy Market: Scope and Methodology

This report on the global liquid biopsy market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global liquid biopsy market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. The report also provides insights into the key trends of the liquid biopsy market such as rise in prevalence of cancer, increasing applications of liquid biopsy, advantages of liquid biopsy over tumor biopsy and improvement in health care infrastructure in emerging economies. Key market indicators influencing the global liquid biopsy market including cost constraints and regulatory landscape have been taken into consideration. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global liquid biopsy market.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global liquid biopsy market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding applications in chronic diseases and historical year-on-year growth have been taken into consideration while estimating the market size.

Liquid Biopsy Market: Segmentation

Based on application, the global liquid biopsy market has been segmented into oncology, NIPT, transplant diagnostics, and others. In terms of circulating biomarkers, the global liquid biopsy market has been classified into circulating tumor cells (CTC), free nucleic acid, and extracellular vesicles (exosomes). In terms of end-user, the market has been segregated into hospitals, reference laboratories, academic and research institutes, and others.

In terms of region, the global liquid biopsy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, Japan, India, Brazil, GCC, South Africa, and Mexico.

Liquid Biopsy Market: Competitive Landscape

The report also profiles major players in the liquid biopsy market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Biocept, Inc., MDxHealth, Myriad Genetics, Inc., Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genomic Health, Inc., and Illumina, Inc. 

The global liquid biopsy market has been segmented as follows:

Global Liquid Biopsy Market, by Application

  • Oncology
  • NIPT
  • Transplant Diagnostics
  • Others

Global Liquid Biopsy Market, by Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Free Nucleic Acid
  • Extracellular vesicles/Exosomes

Global Liquid Biopsy Market, by End-user

  • Hospitals
  • Reference Laboratories
  • Academic and Research Institutes
  • Others

 Global Liquid Biopsy Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Content

Section 1 Preface

1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Liquid Biopsy Market Snapshot
3.2 Market Share Analysis by Region, 2017

Section 4 Market Overview
4.1 Liquid Biopsy Market Taxonomy
4.2 Global Liquid Biopsy Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Liquid Biopsy Market: Market Outlook
4.4 Key Industry Events

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Key Trends
5.5 Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
5.6 Liquid Biopsy Workflow
5.7 Cancer Epidemiology (Region wise)
5.8 Healthcare Overview
5.9. Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy

Section 6 Liquid Biopsy Market Analysis, by Application
6.1 Key Findings
6.2 Introduction
6.3 Global Liquid Biopsy Market Value Share Analysis, by Application
6.4 Global Liquid Biopsy Market Forecast, by Application
6.4.1 Global Liquid Biopsy Market Value Share Analysis, by Oncology
6.4.1.1  Global Liquid Biopsy Market Forecast, by Oncology
6.5 Global Liquid Biopsy Market Forecast, by Application
6.5.1 Oncology
6.5.2 NIPT
6.5.3 Transplant Diagnostics
6.5.4 Others
6.6 Global Liquid Biopsy Market Attractiveness Analysis, by Application

Section 7 Global Liquid Biopsy Market Analysis, by Circulating Biomarkers
7.1 Key Findings
7.2 Introduction
7.3 Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarkers
7.4 Global Liquid Biopsy Market Forecast, by Circulating Biomarkers
7.4.1 Circulating Tumor Cells (CTC)
7.4.2 Free Nucleic Acid
7.4.3 Exosomes
7.5 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 8 Global Liquid Biopsy Market Analysis, by End-user
8.1 Introduction
8.2 Global Liquid Biopsy Market Value Share Analysis, by End-user
8.3 Global Liquid Biopsy Market Forecast, by End-user
8.3.1 Hospitals
8.3.2 Reference Laboratories
8.3.3 Academic and research institutes
8.3.4 Others
8.4 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 9 Global Liquid Biopsy Market Analysis, by Region
9.1 Global Liquid Biopsy Market Value Share Analysis, by Region
9.2 Global Liquid Biopsy Market Forecast, by Region
9.3 Global Liquid Biopsy Market Attractiveness Analysis, by Region

Section 10 North America Liquid Biopsy Market Analysis
10.1 North America Liquid Biopsy Market Overview
10.2 North America Liquid Biopsy Market Value Share Analysis, by Application
10.3 North America Liquid Biopsy Market Forecast, by Application
10.3.1 North America Liquid Biopsy Market Forecast, by Oncology
10.4 North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
10.5 North America Liquid Biopsy Market Forecast, by Circulating Biomarkers
10.6 North America Liquid Biopsy Market Value Share Analysis, by End-user
10.7 North America Liquid Biopsy Market Forecast, by End-user
10.8 North America Liquid Biopsy Market Value Share Analysis, by Country
10.9 North America Liquid Biopsy Market Forecast, by Country
10.9.1 U.S.
10.9.2 Canada
10.10 North America Liquid Biopsy Market Attractiveness Analysis
10.10.1 By Country
10.10.2 By Application
10.10.3 By Circulating Biomarker
10.10.4 By End-user

Section 11 Europe Liquid Biopsy Market Analysis
11.1 Europe Liquid Biopsy Market Overview
11.2 Europe Liquid Biopsy Market Value Share Analysis, by Application
11.3 Europe Liquid Biopsy Market Forecast, by Application
11.3.1 Europe Liquid Biopsy Market Forecast, by Oncology
11.4 Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
11.5 Europe Liquid Biopsy Market Forecast, by Circulating Biomarkers
11.6 Europe Liquid Biopsy Market Value Share Analysis, by End-user
11.7 Europe Liquid Biopsy Market Forecast, by End-user
11.8 Europe Liquid Biopsy Market Value Share Analysis, by Country
11.9 Europe Liquid Biopsy Market Forecast, by Country
11.9.1 Germany
11.9.2 U.K.
11.9.3 France
11.9.4 Spain
11.9.5 Italy
11.9.6 Rest of Europe
11.10 Europe Liquid Biopsy Market Attractiveness Analysis
11.10.1 By Country
11.10.2 By Application
11.10.3 By Circulating Biomarker
11.10.4 By End-user

Section 12 Asia Pacific Liquid Biopsy Market Analysis
12.1 Asia Pacific Liquid Biopsy Market Overview
12.2 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application
12.3 Asia Pacific Liquid Biopsy Market Forecast, by Application
12.3.1 Asia Pacific Liquid Biopsy Market Forecast, by Oncology
12.4 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
12.5 Asia Pacific Liquid Biopsy Market Forecast, by Circulating Biomarkers
12.6 Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user
12.7 Asia Pacific Liquid Biopsy Market Forecast, by End-user
12.8 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country
12.9 Asia Pacific Liquid Biopsy Market Forecast, by Country
12.9.1 China
12.9.2 Japan
12.9.3 India
12.9.4 Australia & New Zealand
12.9.5 Rest of APAC
12.10 Asia Pacific Liquid Biopsy Market Attractiveness Analysis
12.10.1 By Country
12.10.2 By Application
12.10.3 By Circulating Biomarker
12.10.4 By End-user

Section 13 Latin America Liquid Biopsy Market Analysis
13.1 Latin America Liquid Biopsy Market Overview
13.2 Latin America Liquid Biopsy Market Value Share Analysis, by Application
13.3 Latin America Liquid Biopsy Market Forecast, by Application
13.3.1 Latin America Liquid Biopsy Market Forecast, by Oncology
13.4 Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
13.5 Latin America Liquid Biopsy Market Forecast, by Circulating Biomarkers
13.6 Latin America Liquid Biopsy Market Value Share Analysis, by End-user
13.7 Latin America Liquid Biopsy Market Forecast, by End-user
13.8 Latin America Liquid Biopsy Market Value Share Analysis, by Country
13.9 Latin America Liquid Biopsy Market Forecast, by Country
13.9.1 Brazil
13.9.2 Mexico
13.9.3 Rest of LATAM
13.10 Latin America Liquid Biopsy Market Attractiveness Analysis
13.10.1 By Country
13.10.2 By Application
13.10.3 By Circulating Biomarker
13.10.3 By End-user

Section 14 Middle East & Africa (MEA) Liquid Biopsy Market Analysis
14.1 Middle East & Africa Liquid Biopsy Market Overview
14.2 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application
14.3 Middle East & Africa Liquid Biopsy Market Forecast, by Application
14.3.1 Middle East & Africa Liquid Biopsy Market Forecast, by Oncology
14.4 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
14.5 Middle East & Africa Liquid Biopsy Market Forecast, by Circulating Biomarkers
14.6 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user
14.7 Middle East & Africa Liquid Biopsy Market Forecast, by End-user
14.8 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country
14.9 Middle East & Africa Liquid Biopsy Market Forecast, by Country
14.9.1 GCC
14.9.2 South Africa
14.9.3 Israel
14.9.4 Rest of MEA
14.10 Middle East & Africa Liquid Biopsy Market Attractiveness Analysis
14.10.1 By Country
14.10.2 By Application
14.10.3 By Circulating Biomarker
14.10.4 By End-user

Section 15 Company Profiles
15.1 Competition Matrix
15.2 Company Profiles
15.2.1 Biocept, Inc.
15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2 Financial Overview
15.2.1.3 Product Portfolio
15.2.1.4 SWOT Analysis
15.2.1.5 Strategic Overview
15.2.2 MDxHealth
15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2 Financial Overview
15.2.2.3 Product Portfolio
15.2.2.4 SWOT Analysis
15.2.2.5 Strategic Overview
15.2.3 Myriad Genetics, Inc.
15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2 Financial Overview
15.2.3.3 Product Portfolio
15.2.3.4 SWOT Analysis
15.2.3.5 Strategic Overview
15.2.4 Bio-Rad Laboratories
15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2 Financial Overview
15.2.4.3 Product Portfolio
15.2.4.4 SWOT Analysis
15.2.4.5 Strategic Overview
15.2.5 QIAGEN
15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2 Financial Overview
15.2.5.3 Product Portfolio
15.2.5.4 SWOT Analysis
15.2.5.5 Strategic Overview
15.2.6 F. Hoffmann-La Roche Ltd.
15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2 Financial Overview
15.2.6.3 Product Portfolio
15.2.6.4 SWOT Analysis
15.2.6.5 Strategic Overview
15.2.7 Thermo Fisher Scientific Inc.
15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2 Financial Overview
15.2.7.3 Product Portfolio
15.2.7.4 SWOT Analysis
15.2.7.5 Strategic Overview
15.2.8 Genomic Health, Inc.
15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2 Financial Overview
15.2.8.3 Product Portfolio
15.2.8.4 SWOT Analysis
15.2.8.5 Strategic Overview
15.2.9 Illumina, Inc.
15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2 Financial Overview
15.2.9.3 Product Portfolio
15.2.9.4 SWOT Analysis
15.2.9.5 Strategic Overview

List of Table

Table 01: Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
Table 02: Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy
Table 03: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 05: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016–2026
Table 06: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 09: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 10: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 11: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 14: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 15: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 16: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 18: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 19: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 20: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 21: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 22: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 23: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 25: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016–2026
Table 26: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 28: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 29: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 30: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 31: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026

List of Chart

Figure 01: Global Liquid Biopsy Market Snapshot
Figure 02: Global Liquid Biopsy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 03: Global Liquid Biopsy Market Value Share by Application (2017)
Figure 04: Global Liquid Biopsy Market Value Share by Circulating Biomarker (2017)
Figure 05: Global Liquid Biopsy Market Value Share by End-user (2017)
Figure 06: Global Liquid Biopsy Market Value Share by Region (2017)
Figure 07: Global Liquid Biopsy Market Value Share, by Application, 2017 and 2026
Figure 08: Global Liquid Biopsy Market Value Share, by Oncology, 2017 and 2026
Figure 09: Global Liquid Biopsy Market Revenue (US$ Mn) 9Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016–2026
Figure 10: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NIPT, 2016–2026
Figure 11: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transplant Diagnostics, 2016–2026
Figure 12: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 13: Global Liquid Biopsy Market Attractiveness, by Application
Figure 14: Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 15: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Circulating Tumor cells (CTC), 2016-2026
Figure 16: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Free Nucleic Acid, 2016-2026
Figure 17: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Extracellular Vesicles, 2016-2026
Figure 18: Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker
Figure 19: Global Liquid Biopsy Market Value Share, by End-user, 2017 and 2026
Figure 20: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2018–2026
Figure 21: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reference Laboratories, 2018–2026
Figure 22: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic and Research Institutes, 2018–2026
Figure 23: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2018–2026
Figure 24: Global Liquid Biopsy Market Attractiveness, by End-user
Figure 25: Global Liquid Biopsy Market Value Share, by Region, 2017 and 2026
Figure 26: Global Liquid Biopsy Market Attractiveness, by Region, 2018–2026
Figure 27: North America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 28: North America Liquid Biopsy Market Attractiveness Analysis, by Country
Figure 29: North America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 30: North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 31: North America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 32: North America Liquid Biopsy Market Value Share Analysis, by Country, 2017 and 2026
Figure 33: North America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018–2026
Figure 34: North America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018–2026
Figure 35: North America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 36: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 37: Europe Market Liquid Biopsy Attractiveness Analysis, by Country/Sub-Region
Figure 38: Europe Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 39: Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 40: Europe Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 41: Europe Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 42: Europe Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 43: Europe Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 44: Europe Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026
Figure 45: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 46: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Country/Sub-Region
Figure 47: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 48: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 49: Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 50: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 51: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 52: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 53: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026
Figure 54: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 55: Latin America Market Attractiveness Analysis, by Country/Sub-region
Figure 56: Latin America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 57: Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 58: Latin America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 59: Latin America Liquid Biopsy Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 60: Latin America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
Figure 61: Latin America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
Figure 62: Latin America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
Figure 63: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-Region
Figure 65: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 66: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 67: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 68: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 69: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 70: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 71: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *